The National Alliance of Advocates
for Buprenorphine Treatment
Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological
and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2
How the matching system works:
1) Physicians log in, the number of patients seeking treatment in range of your practice location will be displayed.
2) Select patients that best fit your expertise and experience, by clicking on the "select" button.
3) Once you have selected patients, click the"Email selected patients" link. That will bring you to the last step. Patients receive an email instructing them to call your office to further discuss the possibility of treatment. It is then up to the patient to contact you. You may add to or change the outgoing message. Your email address is not given to the patient, or anyone else. Patients cannot email you through the matching system.
Go to Patient Matching System now to log in and try it ......or,
Get More help:
Instruction sheet (2 pages PDF)
Demonstration version of matching system (try it out without actually contacting patients)
How do I add an office location if I have more than one?
Other frequently asked questions FAQs
NOTE: Until more patients become aware of this program, some of you will find "0" patients within range of your practice. As the system becomes more popular this should change. If you selected "receive updates" when you registered, you will receive an email alert when a new patient in range of your practice registers. This option can be turned off when traffic increases. How can I reach more patients?
Patient instruction brochure (PDF) | more buprenorphine related literature
Terms: The intent of this site is to efficiently connect patients in need of treatment for opioid dependence with an Office-based Treatment Provider, certified to prescribe buprenorphine. It is unlawful to use this site to solicit for anything other than stated above. Example: it is inconsistent with the terms to use this site to solicit for “Rapid detox”, “inpatient rehab”, or any other treatment that is not considered Office-based Opioid Dependence Treatment with buprenorphine, and such treatment must be consistent with the physician training established to obtain the DEA waiver to prescribe Schedule III medications, for opioid dependence, in an office based setting, according to the DATA2000 law. If you do not have an “X” number from the DEA you are not authorized to use this patient database. See terms of use for more information.
If you are having problems please contact us at MakeContact@naabt.org for assistance
- U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
- Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.